Comerica Bank’s Neuronetics STIM Stock Holding History

Comerica Bank’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,000	Closed	-$13.7K	–	3809
2025 Q3	$13.7K	Hold	5,000	–	–	﹤0.01%	3187
2025 Q2	$17.4K	Hold	5,000	–	–	﹤0.01%	3083
2025 Q1	$18.4K	Buy	+5,000	New	+$18.3K	﹤0.01%	3039

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Comerica Bank's STIM Position: Q4 2025 in Review

Comerica Bank sold out of Neuronetics (STIM) in Q4 2025, closing a stake of 5,000 shares — an estimated $13.7K sold.

Comerica Bank first reported a position in STIM in Q1 2025 and held it in 3 quarters. The position peaked at $18.4K in Q1 2025. 95 funds tracked by Wall St. Rank hold STIM as of Q4 2025.

Comerica Bank reported no remaining Neuronetics position as of Q4 2025 after selling out during the quarter.
Comerica Bank sold 5,000 Neuronetics shares in Q4 2025, an estimated $13.7K.
Comerica Bank first reported a position in Neuronetics in Q1 2025 and held it in 3 quarters.
Comerica Bank's Neuronetics position peaked at $18.4K in Q1 2025.
95 funds tracked by Wall St. Rank held Neuronetics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.